RETURN TO VIRTUAL EXHIBIT HALL

Verrica

DOWNLOAD MATERIALS

Verrica FINAL 1-4-21, Ms VERRICA CorporateBroch2020_3_no crops.pdf

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. VP-102, our lead product candidate, is a drug-device combination topical therapy to treat molluscum contagiosum. If approved, VP-102 will be marketed in the United States under the conditionally accepted brand name, YCANTH™.

Learn more at verrica.com

Contact Information

Anthony Cavallo
(610) 329-9217
tcavallo@verrica.com

Direct:
(646) 833-8016.
tcavallo@verrica.com